Clinical Trials for Repare Therapeutics

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Repare Therapeutics

Clinical Trials (6)

NCT06560632
Phase 1 Trial of RP-3467 Alone and in Combination With Olaparib in Participants With Advanced Solid Tumors
PHASE1Active, not recruiting
26 participants
Started: Sep 17, 2024 · Completed: Dec 31, 2028
1 condition1 sponsor5 locations
NCT06232408
LIONS (PLK4 Inhibitor in Advanced Solid Tumors)
PHASE1Active, not recruiting
29 participants
Started: Feb 14, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor5 locations
NCT05605509
RP-6306 in Patients With Advanced Cancer
PHASE2Active, not recruiting
28 participants
Started: May 24, 2023 · Completed: May 31, 2026
1 condition2 sponsors6 locations
NCT05566574
A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer
PHASE1/PHASE2Recruiting
84 participants
Started: Sep 30, 2022 · Completed: Sep 30, 2025
2 conditions2 sponsors7 locations
NCT04972110
Study of RP-3500 (Camonsertib) With Niraparib or Olaparib in Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
196 participants
Started: Jul 21, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors13 locations
NCT04855656
Study of RP-6306 Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors
PHASE1Recruiting
364 participants
Started: Apr 30, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors22 locations